An MRI brain tumor segmentation method based on improved U-Net.

Math Biosci Eng

School of Computer and Information Engineering, Nantong Institute of Technology, Nantong 226600, China.

Published: January 2024

In order to improve the segmentation effect of brain tumor images and address the issue of feature information loss during convolutional neural network (CNN) training, we present an MRI brain tumor segmentation method that leverages an enhanced U-Net architecture. First, the ResNet50 network was used as the backbone network of the improved U-Net, the deeper CNN can improve the feature extraction effect. Next, the Residual Module was enhanced by incorporating the Convolutional Block Attention Module (CBAM). To increase characterization capabilities, focus on important features and suppress unnecessary features. Finally, the cross-entropy loss function and the Dice similarity coefficient are mixed to compose the loss function of the network. To solve the class unbalance problem of the data and enhance the tumor area segmentation outcome. The method's segmentation performance was evaluated using the test set. In this test set, the enhanced U-Net achieved an average Intersection over Union (IoU) of 86.64% and a Dice evaluation score of 87.47%. These values were 3.13% and 2.06% higher, respectively, compared to the original U-Net and R-Unet models. Consequently, the proposed enhanced U-Net in this study significantly improves the brain tumor segmentation efficacy, offering valuable technical support for MRI diagnosis and treatment.

Download full-text PDF

Source
http://dx.doi.org/10.3934/mbe.2024033DOI Listing

Publication Analysis

Top Keywords

brain tumor
16
tumor segmentation
12
enhanced u-net
12
mri brain
8
segmentation method
8
improved u-net
8
loss function
8
test set
8
segmentation
6
u-net
6

Similar Publications

Histologic transformation from non-small cell to small cell lung cancer (SCLC) is a resistance mechanism to immune checkpoint inhibitors. We report herein a case of lung adenocarcinoma who developed liver and brain metastases during adjuvant atezolizumab therapy. The patient underwent a craniotomy to resect a brain metastasis, which was pathologically diagnosed as SCLC.

View Article and Find Full Text PDF

Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor.

Neuro Oncol

December 2024

Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, Republic of Korea.

Background: NF2-related schwannomatosis (NF2-SWN) is associated with multiple benign tumors in the nervous system. NF2-SWN, caused by mutations in the NF2 gene, has developed into intracranial and spinal schwannomas. Because of the high surgical risk and frequent recurrence of multiple tumors, targeted therapy is necessary.

View Article and Find Full Text PDF

Background: Selinexor is a selective inhibitor of exportin-1 (XPO1), a key mediator of the nucleocytoplasmic transport for molecules critical to tumor cell survival. Selinexor's lethality is generally associated with the induction of apoptosis, and in some cases, with autophagy-induced apoptosis. We performed this study to determine Selinexor's action in glioblastoma (GBM) cells, which are notoriously resistant to apoptosis.

View Article and Find Full Text PDF

Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogramming.

J Nanobiotechnology

December 2024

Key Laboratory of Emergency and Trauma of Ministry of Education, Engineering Research Center for Hainan Biological Sample Resources of Major Diseases, the Hainan Branch of National Clinical Research Center for Cancer, the First Affiliated Hospital, Hainan Medical University, Haikou, 570102, China.

Limited drug accumulation and an immunosuppressive microenvironment are the major bottlenecks in the treatment of glioblastoma multiforme (GBM). Herein, we report a copper-coordination driven brain-targeting nanoassembly (TCe6@Cu/TP5 NPs) for site-specific delivery of therapeutic agents and efficient immunotherapy by activating the cGAS-STING pathway and downregulating the expression of PD-L1. To achieve this, the mitochondria-targeting triphenylphosphorus (TPP) was linked to photosensitizer Chlorin e6 (Ce6) to form TPP-Ce6 (TCe6), which was then self-assembled with copper ions and thymopentin (TP5) to obtain TCe6@Cu/TP5 NPs.

View Article and Find Full Text PDF

Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review.

BMC Cancer

December 2024

Department of Data Science, Faculty of Interdisciplinary Science and Technology, Tarbiat Modares University, Tehran, Iran.

Glioblastoma Multiforme (GBM), classified as a grade IV glioma by the World Health Organization (WHO), is a prevalent and notably aggressive form of brain tumor derived from glial cells. It stands as one of the most severe forms of primary brain cancer in humans. The median survival time of GBM patients is only 12-15 months, making it the most lethal type of brain tumor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!